Current Status of Mycosynthetix Projects

As well as working with our clients, Mycosynthetix has in-house discovery projects addressing cancer and neglected diseases; these are summarized in the table below together with our fungal product out-licensing opportunities. Please contact Dr. Cedric Pearce at cpearce@mycosynthetix.com for additional details.

Application	Target	Status January 2010
Cancer Collaboration with Professors N. Oberlies and D. Kroll of the the University of North Carolina Greensboro and North Carolina Central University and funded by a Program Grant from the National Cancer Institute (PO1-CA125066) through the Ohio State University (Professor Douglas Kinghorn).	Cytotoxicity, various cells	Novel active compounds identified and evaluated in the NCI 60 cell line panel. Provisional patents being filed. Other lead fungi being analyzed and evaluated.
Antibiotics Collaboration with Professor Scott Franzblau of the Institute for Tuberculosis Research, University of Illinois - Chicago.	Tuberculosis	Active fungi being evaluated and prioritized. Currently funded by the National Institute of Allergy and Infectious Diseases.
Antiparasitic Collaboration with Professors B. Baker and D. Kyle of the University of South Florida to discover new malaria medicines.	Malaria	Screening and evaluation of active fungi on-going. Currently funded by Medicines for Malaria Venture, Switzerland.
Agriculture	Herbicide	Novel herbicide identified and patented (by Dow AgroSciences LLC - see elsewhere on this site) now under development in our laboratories.

Home : : Science & Technology : : Current Projects : : News & Publications : : Contact

	© 2006-2009 Mycosynthetix, Inc. All rights reserved.